Search PubMed⌕ Search

Biomedical subjects

R Yu

Publications and source records attributed to R Yu.

202 records · Page 12Linked to original sources

Practical synthesis, separation, and stereochemical assignment of the PMPA pro-drug GS-7340.

The practical synthesis of a mixed phenoxy-amidate derivative of PMPA with high oral bioavailability and favorable pharmacokinetics is described. The non-stereoselective synthetic route produces a 1:1 mixture of two diastereomers at phosphorous. Simulated moving bed chromatography using Chiralpak AS enabled kilo-scale isolation of the more potent diastereomer (GS-7340). The GS-7340 phosphorous chiral center was found to be (S) by X-ray crystallography.

Adenine↗

Successful treatment of chromoblastomycosis with itraconazole.

An unusual severe case of chromoblastomycosis due to Cladosporium carrionii unresponsive to 5-FC and some azoles is reported. With oral itraconazole at a dosage of 100 mg d(-1) for 15 months (total dose 45.5 g) the patient had a complete clinical and mycological recovery without any side-effects.

Chromoblastomycosis↗

Color stability of elastomers for maxillofacial appliances.

The color stability of polyvinyl chloride, polyurethane, and silicone polymers for maxillofacial applications was determined after accelerated aging using reflectance spectrophotometry. On the basis of color stability after accelerated aging, and ease of processing, several silicone materials were the most promising.

Color↗

Measurement of benzene in human breath associated with an environmental exposure.

The concentration of benzene in breath was measured after exposure to environmental benzene. Five volunteers were exposed to environmental tobacco smoke at different exposure levels and for different exposure durations. The breath samples were collected before, during, and postexposure for up to three hours. Benzene in breath was confirmed as a short-term biomarker of environmental benzene exposure at the sub-ppm level. Less than 10% of the inhaled benzene was expired within three hours following two-hour inhalation exposures, with a greater percentage expired following shorter exposures. An average of 64% percent of the inhaled benzene was absorbed through the lung barrier, with the percentage absorbed decreasing with continued exposure. Benzene biological half-lives of 7.6 and 68 minutes were calculated empirically using a two-compartment model based on the exponential benzene decay curve after correcting the breath concentrations for background breath concentrations. The breath concentration calculated at the end of the exposure by extrapolation of the postexposure breath samples demonstrates a discontinuity with the breath concentration collected during exposure, consistent with equilibrium exchange between blood and breath.

Adult↗